One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study.

MLA

Bassi, Marta, et al. “One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study.” Life (2075-1729), vol. 14, no. 10, Oct. 2024, p. 1309. EBSCOhost, https://doi.org/10.3390/life14101309.

APA

Bassi, M., Strati, M. F., Spiandorello, G., Scalas, M., Cresta, F., Calevo, M. G., d’Annunzio, G., Castellani, C., Minuto, N., Maghnie, M., & Casciaro, R. (2024). One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study. Life (2075-1729), 14(10), 1309. https://doi.org/10.3390/life14101309

Chicago

Bassi, Marta, Marina Francesca Strati, Gaia Spiandorello, Marta Scalas, Federico Cresta, Maria Grazia Calevo, Giuseppe d’Annunzio, et al. 2024. “One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study.” Life (2075-1729) 14 (10): 1309. doi:10.3390/life14101309.